• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过基因组-转录组和单细胞蛋白标志物分析研究转移性上尿路上皮癌的演进。

The evolution of metastatic upper tract urothelial carcinoma through genomic-transcriptomic and single-cell protein markers analysis.

机构信息

Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, 10065, USA.

Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, 10021, USA.

出版信息

Nat Commun. 2024 Mar 18;15(1):2009. doi: 10.1038/s41467-024-46320-w.

DOI:10.1038/s41467-024-46320-w
PMID:38499531
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10948878/
Abstract

The molecular characteristics of metastatic upper tract urothelial carcinoma (UTUC) are not well understood, and there is a lack of knowledge regarding the genomic and transcriptomic differences between primary and metastatic UTUC. To address these gaps, we integrate whole-exome sequencing, RNA sequencing, and Imaging Mass Cytometry using lanthanide metal-conjugated antibodies of 44 tumor samples from 28 patients with high-grade primary and metastatic UTUC. We perform a spatially-resolved single-cell analysis of cancer, immune, and stromal cells to understand the evolution of primary to metastatic UTUC. We discover that actionable genomic alterations are frequently discordant between primary and metastatic UTUC tumors in the same patient. In contrast, molecular subtype membership and immune depletion signature are stable across primary and matched metastatic UTUC. Molecular and immune subtypes are consistent between bulk RNA-sequencing and mass cytometry of protein markers from 340,798 single cells. Molecular subtypes at the single-cell level are highly conserved between primary and metastatic UTUC tumors within the same patient.

摘要

转移性上尿路尿路上皮癌(UTUC)的分子特征尚不清楚,对于原发性和转移性 UTUC 之间的基因组和转录组差异知之甚少。为了解决这些空白,我们整合了全外显子测序、RNA 测序和使用镧系金属偶联抗体的成像质谱细胞检测,对 28 名高级别原发性和转移性 UTUC 患者的 44 个肿瘤样本进行了分析。我们对癌症、免疫和基质细胞进行了空间分辨的单细胞分析,以了解原发性向转移性 UTUC 的演变。我们发现,同一患者的原发性和转移性 UTUC 肿瘤之间,可采取行动的基因组改变经常不一致。相比之下,分子亚型成员和免疫耗竭特征在原发性和匹配的转移性 UTUC 之间是稳定的。来自 340798 个单细胞的批量 RNA 测序和蛋白标志物的质谱细胞检测结果表明,分子和免疫亚型是一致的。在同一患者中,原发性和转移性 UTUC 肿瘤之间的单细胞水平的分子亚型高度保守。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4ad/10948878/f69675c1931b/41467_2024_46320_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4ad/10948878/f417cb839284/41467_2024_46320_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4ad/10948878/586937f28dfc/41467_2024_46320_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4ad/10948878/e80e47c96f34/41467_2024_46320_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4ad/10948878/258b0c1eb143/41467_2024_46320_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4ad/10948878/f69675c1931b/41467_2024_46320_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4ad/10948878/f417cb839284/41467_2024_46320_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4ad/10948878/586937f28dfc/41467_2024_46320_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4ad/10948878/e80e47c96f34/41467_2024_46320_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4ad/10948878/258b0c1eb143/41467_2024_46320_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4ad/10948878/f69675c1931b/41467_2024_46320_Fig5_HTML.jpg

相似文献

1
The evolution of metastatic upper tract urothelial carcinoma through genomic-transcriptomic and single-cell protein markers analysis.通过基因组-转录组和单细胞蛋白标志物分析研究转移性上尿路上皮癌的演进。
Nat Commun. 2024 Mar 18;15(1):2009. doi: 10.1038/s41467-024-46320-w.
2
Genomic Characterization of Upper Tract Urothelial Carcinoma.上尿路尿路上皮癌的基因组特征
Eur Urol. 2015 Dec;68(6):970-7. doi: 10.1016/j.eururo.2015.07.039. Epub 2015 Aug 14.
3
Investigating cellular similarities and differences between upper tract urothelial carcinoma and bladder urothelial carcinoma using single-cell sequencing.利用单细胞测序技术研究上尿路尿路上皮癌和膀胱尿路上皮癌之间的细胞相似性和差异性。
Front Immunol. 2024 Jun 6;15:1298087. doi: 10.3389/fimmu.2024.1298087. eCollection 2024.
4
Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsy.通过快速尸检揭示转移性上下尿路尿路上皮癌的基因组差异。
JCI Insight. 2019 May 30;5(13):128728. doi: 10.1172/jci.insight.128728.
5
Expression Analysis of Same-Patient Metachronous and Synchronous Upper Tract and Bladder Urothelial Carcinoma.同一患者的异时性和同时性上尿路和膀胱尿路上皮癌的表达分析。
J Urol. 2021 Sep;206(3):548-557. doi: 10.1097/JU.0000000000001788. Epub 2021 Apr 21.
6
Comparison of Genomic Characterization in Upper Tract Urothelial Carcinoma and Urothelial Carcinoma of the Bladder.上尿路尿路上皮癌与膀胱尿路上皮癌的基因组特征比较
Oncologist. 2021 Aug;26(8):e1395-e1405. doi: 10.1002/onco.13839. Epub 2021 Jun 8.
7
The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder.原发性上尿路尿路上皮癌与膀胱配对尿路上皮癌的克隆关系。
Int J Cancer. 2021 Feb 15;148(4):981-987. doi: 10.1002/ijc.33327. Epub 2020 Oct 13.
8
Comprehensive Genomic Characterization of Upper Tract Urothelial Carcinoma.上尿路尿路上皮癌的全面基因组特征分析。
Eur Urol. 2017 Oct;72(4):641-649. doi: 10.1016/j.eururo.2017.05.048. Epub 2017 Jun 7.
9
Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma.上尿路和膀胱尿路上皮癌之间的克隆相关性和突变差异。
Clin Cancer Res. 2019 Feb 1;25(3):967-976. doi: 10.1158/1078-0432.CCR-18-2039. Epub 2018 Oct 23.
10
Genomics in upper tract urothelial carcinoma.上尿路尿路上皮癌的基因组学
Curr Opin Urol. 2017 Jan;27(1):35-40. doi: 10.1097/MOU.0000000000000341.

引用本文的文献

1
Machine Learning-Based Gene Expression Analysis to Identify Prognostic Biomarkers in Upper Tract Urothelial Carcinoma.基于机器学习的基因表达分析以鉴定上尿路尿路上皮癌的预后生物标志物
Cancers (Basel). 2025 Aug 11;17(16):2619. doi: 10.3390/cancers17162619.
2
Identification and characterization of cell niches in tissue from spatial omics data at single-cell resolution.在单细胞分辨率下从空间组学数据中鉴定和表征组织中的细胞生态位。
Nat Commun. 2025 Feb 16;16(1):1693. doi: 10.1038/s41467-025-57029-9.
3
Molecular Heterogeneity and Immune Infiltration Drive Clinical Outcomes in Upper Tract Urothelial Carcinoma.

本文引用的文献

1
Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution.分子尿路上皮肿瘤细胞亚型在转移进化过程中保持稳定。
Eur Urol. 2024 Apr;85(4):328-332. doi: 10.1016/j.eururo.2023.03.020. Epub 2023 Apr 6.
2
The spatial landscape of lung pathology during COVID-19 progression.新型冠状病毒肺炎进展过程中肺部病理的空间格局
Nature. 2021 May;593(7860):564-569. doi: 10.1038/s41586-021-03475-6. Epub 2021 Mar 29.
3
Whole genome sequencing of metastatic colorectal cancer reveals prior treatment effects and specific metastasis features.
分子异质性和免疫浸润驱动上尿路尿路上皮癌的临床结局
Eur Urol. 2025 Mar;87(3):342-354. doi: 10.1016/j.eururo.2024.10.024. Epub 2024 Nov 16.
4
Pre-treatment metastatic biopsy: a step towards precision oncology for urothelial cancer.治疗前转移性活检:迈向尿路上皮癌精准肿瘤学的一步。
Nat Rev Urol. 2025 May;22(5):256-267. doi: 10.1038/s41585-024-00951-2. Epub 2024 Oct 29.
转移性结直肠癌的全基因组测序揭示了既往治疗效果和特定转移特征。
Nat Commun. 2021 Jan 25;12(1):574. doi: 10.1038/s41467-020-20887-6.
4
Molecular Characterization of Upper Tract Urothelial Carcinoma in the Era of Next-generation Sequencing: A Systematic Review of the Current Literature.下一代测序时代的上尿路尿路上皮癌的分子特征:当前文献的系统评价。
Eur Urol. 2020 Aug;78(2):209-220. doi: 10.1016/j.eururo.2020.05.039. Epub 2020 Jun 20.
5
Epithelial plasticity can generate multi-lineage phenotypes in human and murine bladder cancers.上皮可塑性可在人类和鼠类膀胱癌中产生多谱系表型。
Nat Commun. 2020 May 21;11(1):2540. doi: 10.1038/s41467-020-16162-3.
6
Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases.多癌种分析克隆性和配对原发性肿瘤及转移灶中系统性播散的时间。
Nat Genet. 2020 Jul;52(7):701-708. doi: 10.1038/s41588-020-0628-z. Epub 2020 May 18.
7
Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts.利用患者来源异种移植模型对尿路上皮癌的生物学和遗传多样性进行研究。
Nat Commun. 2020 Apr 24;11(1):1975. doi: 10.1038/s41467-020-15885-7.
8
Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance.肿瘤内异质性:治疗抵抗的罗塞塔石碑。
Cancer Cell. 2020 Apr 13;37(4):471-484. doi: 10.1016/j.ccell.2020.03.007.
9
ilastik: interactive machine learning for (bio)image analysis.ilastik:用于(生物)图像处理的交互式机器学习。
Nat Methods. 2019 Dec;16(12):1226-1232. doi: 10.1038/s41592-019-0582-9. Epub 2019 Sep 30.
10
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer.肌肉浸润性膀胱癌的共识分子分类。
Eur Urol. 2020 Apr;77(4):420-433. doi: 10.1016/j.eururo.2019.09.006. Epub 2019 Sep 26.